Role of the nitric oxide-cGMP pathway in the cardiovascular effects of anesthetic agents: A review

Acta Anaesthesiologica Belgica

Volumn 50, Issue 3, 1999, Pages 105-112

  Lecomte, P V ^a   De Mulder, P A ^a   Adriaensen, H F ^a   De Hert, S G ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Anesthetic; Desflurane; Enflurane; Etomidat e; Function; Halothane; Heart; Intravenous; Nitric Oxide (NO); Nitrous Oxide; Propofol; Sevoflurane; Taoflurane; Thiopental; Violate

Indexed keywords

ANESTHETIC AGENT; CYCLIC GMP; DESFLURANE; ENFLURANE; ETOMIDATE; HALOTHANE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROUS OXIDE; PROPOFOL; SEVOFLURANE; THIOPENTAL; VOLATILE AGENT;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR EFFECT; CLINICAL MEDICINE; CORONARY BLOOD VESSEL; DRUG EFFECT; ENDOTHELIUM CELL; HEART FUNCTION; HEART MUSCLE; HUMAN; PATHOPHYSIOLOGY;

ANESTHETICS; ANIMALS; CYCLIC GMP; HEART; HUMANS; MYOCARDIAL CONTRACTION; NITRIC OXIDE;

EID: 0032845233     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)